Almost all participants with diabetes also had hypertension with differentially high uptake of reno protective drugs such as angiotensin converting enzyme (ACE) inhibitors and angiotensine receptor inhibitors among those with diabetes at baseline (in line with guidelines) [53, 55–57]. This evidence concerns the gene ACE and Hypertension.